TABLE 5.
Minimum inhibitory concentration (MIC; μg/ml) values of antifungal agents for the Aspergillus tamarii isolates reported previously from various human infections.
| References | Kredics et al., 2007n = 1 (E-test) | Baranyi et al., 2013n = 4 (E-test) | Cuadros et al., 2018n = 1 (E-test) | Manikandan et al., 2019n = 1 (BMD) | Al-Hatmi et al., 2019n = 4 (BMD) |
Castro et al., 2019 |
||
| n = 3 (BMD) | n = 3 (E-test) | |||||||
| Antifungal agent | AMB | 0.125 | 0.002–0.008 | 0.25 | ≤0.5 | 0.5–1 (0.59) | 0.12 | 0.5–2 |
| AND | – | 0.38–1 | – | – | – | 0.015–0.03 | – | |
| CLT | – | – | – | ≤0.5 | – | – | – | |
| CSP | – | 0.016–0.25 | 0.5 | – | – | ≤0.03 | – | |
| ECN | 0.064 | – | – | ≥1 | – | – | – | |
| FLC | >256 | >32 | >256 | – | – | – | – | |
| ITC | 0.064 | 0.38–0.75 | – | ≤0.25 | 0.5–2 (0.84) | ≤ 0.03–0.06 | 0.5–1 | |
| KTC | 0.25 | – | – | ≥1 | – | – | – | |
| MCF | – | – | – | – | – | ≤0.03 | 0.06–0.25 | |
| NTM | >1024 | – | – | ≥32 | 4–8(5.65) | – | – | |
| PSC | – | 0.125–0.94 | 0.094 | – | – | ≤ 0.03–0.06 | 0.125–0.25 | |
| TRB | – | – | – | – | – | – | – | |
| VRC | 0.125 | 0.125–0.19 | – | ≥1 | 0.5–4 (0.133) | 0.06–0.25 | 0.64–0.125 | |
We only included data from papers using molecular or MALDI-TOF MS analyses for the confirmation of morphological identification. AMB, amphotericin B; AND, anidulafungin; BMD, broth microdilution; CLT, clotrimazole; CSP, caspofungin; ECN, econazole; FLC, fluconazole; ITC, itraconazole; KTC, ketoconazole; MCF, micafungin; NTM, natamycin; PSC, posaconazole; TRB, terbinafine; VRC, voriconazole.